
The Cooper Companies COO
$ 61.45
0.67%
Quarterly report 2025-Q4
added 03-06-2026
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
199 M |
Market Cap[1] |
$ 12.2 B |
EBITDA (LTM) |
$ 1.04 B |
P/E (LTM) |
28.89 |
P/S (LTM) |
3.01 |
EPS (LTM) |
2.12 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Glaukos Corporation
GKOS
|
$ 101.85 | -4.38 % | $ 5.82 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 66.57 | 1.39 % | $ 40.4 B | NYSE | ||
|
Intuitive Surgical
ISRG
|
$ 423.04 | -0.14 % | $ 151 B | Nasdaq Global Select Market,SPB | ||
|
ICU Medical
ICUI
|
$ 136.84 | -1.47 % | $ 3.37 B | Nasdaq Global Select Market,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 114.35 | -1.09 % | $ 3.66 B | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.11 | -1.79 % | $ 190 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 95.03 | 0.51 % | $ 2.15 B | Nasdaq Global Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Masimo Corporation
MASI
|
$ 178.43 | -0.01 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.04 | 5.44 % | $ 93.4 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Milestone Scientific
MLSS
|
$ 0.38 | -4.1 % | $ 31.2 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
electroCore
ECOR
|
$ 9.69 | 4.87 % | $ 82.2 K | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 23.72 | 0.21 % | $ 3.98 B | NYSE | ||
|
Haemonetics Corporation
HAE
|
$ 67.57 | 0.79 % | $ 3.19 B | NYSE,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
STERIS plc
STE
|
$ 211.96 | -1.6 % | $ 20.9 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 29.74 | 2.27 % | $ 1.47 B | Nasdaq Global Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.14 | 0.88 % | $ 189 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 129.3 | -0.28 % | $ 5.77 B | NYSE,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 63.32 | -0.67 % | $ 3.75 B | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 66.47 | 0.29 % | $ 215 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 320.72 | -0.34 % | $ 23.2 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 10.45 | 1.51 % | $ 2.08 B | Nasdaq Global Select Market,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 25.23 | 1.98 % | $ 1.7 B | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.69 | -5.89 % | $ 20.7 M | NYSE American | ||
|
Pro-Dex
PDEX
|
$ 66.18 | -1.96 % | $ 218 M | Nasdaq Global Select Market | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
BioLife Solutions
BLFS
|
$ 25.16 | -0.36 % | $ 1.2 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.98 | -4.81 % | $ 180 M | NYSE American | ||
|
Baxter International
BAX
|
$ 18.91 | -1.72 % | $ 9.7 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 191.48 | -5.87 % | $ 28 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 27.88 | -0.75 % | $ 1.33 B | Nasdaq Global Market,SPB | ||
|
Harvard Bioscience
HBIO
|
$ 5.86 | -1.51 % | $ 260 M | Nasdaq Global Market | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
AngioDynamics
ANGO
|
$ 11.54 | -2.12 % | $ 471 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 146.84 | -1.06 % | $ 42.2 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 3.65 | -1.35 % | $ 38.7 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 4.29 | 1.3 % | $ 315 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 123.72 | 0.8 % | $ 6.96 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.